GlassScriptPhysician profile
Lyle G Breeding
NPI 1063625317
$16,120.10
in general payments reported to CMS, 2019-2025
19 companies · $8,597 in 2025
The $8,597 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $141 · 2021: $143 · 2022: $730 · 2023: $3,772 · 2024: $2,177 · 2025: $8,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,422 · Food and Beverage: $5,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,422.13 |
| Food and Beverage | $5,122.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,562.96 | 2022-2025 | Hawkone, Endurant Iis, Heli-Fx Endoanchor System |
| Penumbra, INC. | $3,215.57 | 2019-2025 | Indigo System, Ruby Coil, Penumbra System |
| Silk Road Medical, INC. | $2,695.77 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $1,224.31 | 2019-2025 | Gore Excluder Aaa Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Endologix LLC | $306.10 | 2022 | |
| Medtronic Vascular, INC. | $286.26 | 2019 | |
| Stryker Corporation | $167.31 | 2023 | Reunion |
| Misonix INC | $142.77 | 2021 | |
| Inari Medical, INC. | $122.70 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $57.08 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $56.99 | 2022-2023 | |
| Smith+Nephew, INC. | $48.41 | 2025 | Grafix Pl |
| Abbvie INC. | $45.75 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps |
| Mozarc Medical US LLC | $41.36 | 2024 | Palindrome |
| Boston Scientific Corporation | $34.79 | 2025 | Enroute Transcarotid Neuroprotection System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $33.76 | 2024 | Ovitex 2s |
| Davol INC. | $32.22 | 2022 | |
| Organogenesis INC. | $28.37 | 2020 | |
| Angiodynamics, INC. | $17.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyle Breeding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.